Dolby Laboratories (DLB) Tops Q2 EPS by 36c, Offers Q3 & FY Guidance

Dolby Laboratories (NYSE: DLB) reported Q2 EPS of $0.82, $0.36 better than the analyst estimate of $0.46. Revenue for the quarter came in at $274.3 million versus the consensus estimate of $263.97 million.

GUIDANCE:

Dolby Laboratories sees Q3 2016 EPS of $0.62-$0.68, versus the consensus of $0.40. Dolby Laboratories sees Q3 2016 revenue of $260-275 million, versus the consensus of $253.70 million.

Dolby Laboratories sees FY2016 revenue of $1.0-1.03 billion, versus the consensus of $1.02 billion.

For earnings history and earnings-related data on Dolby Laboratories (DLB) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• Halozyme names David Ramsay as president of drug delivery
• After-Hours Stock Movers: NKE, BE, STZ, RIG